Diffuse large B-cell lymphoma
Showing 9976 - 10000 of >10,000
Microvascular Disease Trial in Mainz (Assessment of microvascular function with intracoronary hemodilution)
Recruiting
- Microvascular Disease
- Assessment of microvascular function with intracoronary hemodilution
-
Mainz, RLP, GermanyUniversitätsmedizin Mainz
Mar 29, 2022
Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary
Recruiting
- Breast Cancer
- +2 more
- Systemic therapy for 12 weeks after primary registration
- +3 more
-
Tokyo, JapanTokyo Medical and Dental Univetsity
Nov 15, 2023
Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)
Not yet recruiting
- Acute Graft Versus Host Disease
- Hematopoietic and Lymphoid System Neoplasm
- Fecal Microbiota Transplantation Capsule
- Placebo
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 6, 2023
HIV Trial in Baltimore, Saint Louis (gp160 Vaccine (Immuno-AG), Hepatitis B Vaccine (Recombinant))
Completed
- HIV Infections
- gp160 Vaccine (Immuno-AG)
- Hepatitis B Vaccine (Recombinant)
-
Baltimore, Maryland
- +1 more
Oct 26, 2021
Postoperative Nausea and Vomiting, Breast Cancer Female Trial in Busan (Ramosetron Hydrochloride)
Completed
- Postoperative Nausea and Vomiting
- Breast Cancer Female
- Ramosetron Hydrochloride
-
Busan, Korea, Republic ofPusan National University Hopsital
Apr 12, 2022
Acute Leukemia, MDS, Myeloproliferative Tumor Trial in Minneapolis (VIC- 1911)
Recruiting
- Acute Leukemia
- +3 more
- VIC- 1911
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Pulmonary Osteosarcoma Trial (RNA-LP vaccine)
Not yet recruiting
- Pulmonary Osteosarcoma
- RNA-LP vaccine
- (no location specified)
Jan 25, 2023
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer Trial in Worldwide (Administration of
Recruiting
- Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
- Administration of ceralasertib in combination with carboplatin
- +3 more
-
Duarte, California
- +26 more
Aug 17, 2022
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in
Active, not recruiting
- Stage IA Non-Small Cell Lung Carcinoma
- +3 more
- Computed Tomography Perfusion Imaging
- +2 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
Frailty Syndrome Trial in Erlangen (WB-EMS, social contact control group)
Completed
- Frailty Syndrome
- WB-EMS
- social contact control group
-
Erlangen, Bavaria, GermanyInstitute of Medical Physics, University of Erlangen-Nürnberg
Jul 18, 2022
Heart Failure Trial in São Paulo (Nursing teleconsultation for lifestyle changes)
Not yet recruiting
- Heart Failure
- Nursing teleconsultation for lifestyle changes
-
São Paulo, BrazilHeart Institute (InCor), Hospital das Clinicas do HCFMUSP
Feb 3, 2022
AML Trial in Hangzhou (NKG2D CAR-NK)
Recruiting
- AML
- NKG2D CAR-NK
-
Hangzhou, Zhejiang, China
- +1 more
Feb 17, 2023
Bone Marrow Grafting for Leukemia and Lymphoma
Enrolling by invitation
- Leukemia
- +2 more
- collection and storage of tissue samples for research
-
Stanford, CaliforniaStanford University School of Medicine
Jul 29, 2021
Blood Vessel Study
Completed
- Cardiovascular Disease
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 25, 2023
Psoriatic Arthritis, Obesity Trial in Calgary (BWLT, Waitlist Control for BWLT)
Recruiting
- Psoriatic Arthritis
- Obesity
- BWLT
- Waitlist Control for BWLT
-
Calgary, Alberta, CanadaBehavioural Medicine Laboratory
May 16, 2022
Hepatitis B Vaccine Trial (60 µg dose hepatitis B vaccine, 20 µg dose hepatitis B vaccine)
Completed
- Hepatitis B Vaccine
- 60 µg dose hepatitis B vaccine
- 20 µg dose hepatitis B vaccine
- (no location specified)
Nov 26, 2021
AdV Infection, EBV Infection, CMV Infection Trial in Worldwide (Multivirus (CMV, EBV, AdV)-specific T cells)
Recruiting
- AdV Infection
- +3 more
- Multivirus (CMV, EBV, AdV)-specific T cells
-
Brussels, Belgium
- +25 more
Feb 14, 2022
Bronchiolitis Obliterans, Graft Vs Host Disease Trial in Palo Alto (Pirfenidone 267 MG [Esbriet])
Completed
- Bronchiolitis Obliterans
- Graft Vs Host Disease
- Pirfenidone 267 MG [Esbriet]
-
Palo Alto, CaliforniaStanford University School of Medicine
Jun 8, 2022
Esophageal Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab, Carboplatin or Cisplatin, Docetaxel)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 30, 2022
Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United
Recruiting
- Relapsing Multiple Sclerosis
- +2 more
- Autologous Hematopoietic Stem Cell Transplantation
- Best Available Therapy (BAT)
-
Palo Alto, California
- +20 more
Jan 25, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Suspended
- Anatomic Stage I Breast Cancer AJCC v8
- +23 more
- Short-Term Fasting
- Chemotherapy
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
Urothelial Carcinoma Trial in Worldwide (Zilovertamab vedotin)
Recruiting
- Urothelial Carcinoma
- Zilovertamab vedotin
-
Cleveland, Ohio
- +11 more
Jan 25, 2023